Is it safe and efficacious to remove central lines in pediatric bone marrow transplant patients with platelets less than 20,000/μl?-Reference-Cited by-同舟云学术

Is it safe and efficacious to remove central lines in pediatric bone marrow transplant patients with platelets less than 20,000/μl?

Published:2022-01-15 Issue:1 Volume:3 Page:154-158
ISSN:2688-6146
Container-title:eJHaem
language:en
Short-container-title:eJHaem

Author:

Marwah Priya¹,Ramprakash Stalin²³,Prasad T R Sai²³,Gizhlaryan Mane²,Trivedi Deepa²⁴,Shah Vaibhav²⁴,Chitaliya Amit⁴,Elizabeth Sandeep²³,Agarwal Rajat Kumar²⁵^ORCID,Dhanya Rakesh²,Faulkner Lawrence²⁶

Affiliation:

1. Department of Pediatrics Mahatma Gandhi University of Medical Sciences and Technology Jaipur India

2. Sankalp India Foundation Bangalore India

3. Sankalp‐People Tree Centre for Paediatric Bone Marrow Transplantation Bangalore India

4. Sankalp‐CIMS Centre for Paediatric BMT Ahmedabad India

5. Jagriti InnoHealth Platforms Pvt. Ltd. Bangalore India

6. Cure2Children Foundation Florence Italy

Publisher

Wiley

Subject

General Earth and Planetary Sciences

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jha2.379

Reference14 articles.

1. Central venous catheters and biofilms: where do we stand in 2017?

2. Administration of blood products to prevent bleeding complications associated with central venous catheter insertion in patients at risk: a systematic review

3. Comparison of different platelet transfusion thresholds prior to insertion of central lines in patients with thrombocytopenia

4. Prophylactic platelet transfusion prior to central venous catheter placement in patients with thrombocytopenia: study protocol for a randomised controlled trial

5. A prospective international cooperative information technology platform built using open-source tools for improving the access to and safety of bone marrow transplantation in low- and middle-income countries: Figure 1